Genetic Clues for Skin Cancer Therapies Syracuse NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

Jon Curtis Lochner
(315) 492-5727
4900 Broad Road
Syracuse, NY
JON LOCHNER, MD
(315) 492-5727
4900 Broad Road
Syracuse, NY
JOYCE FARAH, MD
(315) 422-8331
1000 E Genesee Street
Syracuse, NY
Michele Susan Green, MD
315-638-1994
3448 State Route 31
Baldwinsville, NY
Andreas Perl, MD
315-464-3836
750 E Adams St
Syracuse, NY
Donald L LeVin
(315) 452-2600
5100 W Taft Rd
Liverpool, NY
DONALD LEVIN, MD
(315) 452-2600
5100 W Taft Road
Liverpool, NY
RAMSAY FARAH, MD
(315) 422-8331
1000 E Genesee Street
Syracuse, NY
Karen Meryl Green, MD
315-478-3311
1304 Buckley Rd
Syracuse, NY
Madhavi Menon, MD
315-701-0070
1000 E Genesee St Ste 100
Syracuse, NY
Data Provided by:
    

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Filling in Wrinkles with Dermal Fillers Syracuse NY
In the summer, there are many different things that people like to do in order to have fun. Some people like to enjoy outdoor activities such as sports, while other people like to lie out in the sun for long periods of time and tan. Tanning is something that has become more and more popular amongst people since the early twentieth century, but too much tanning can lead to things like skin cancer and premature wrinkles.
- Getting a Botox Cosmetic Injection Syracuse NY
- Delayed Prostate Cancer Therapy Syracuse NY
- Breast Cancer Treatment Syracuse NY
- Gene Mutation in Dogs Syracuse NY
- Risks for Childhood Cancer Survivors Syracuse NY
- High Levels of Selenium Decreases Incidence of Skin Cancer. Syracuse NY
- Healing Facial Spider Veins Syracuse NY
- Follow Up After Skin Cancer Syracuse NY
- Risk Factors for Squamous Cell Cancer of the Skin Syracuse NY